German businessman Thomas Strungmann has an estimated net worth of $3.3 billion as of April 2016, according to Forbes.

This 63-year old businessman is an alumnus of Augsburg University where he completed his Masters of Business Administration. He is currently married and has four children. Along with his twin, Andreas, Thomas Strungmann is considered as among the most successful pharmaceutical entrepreneurs in Germany. It was in 1986, when the siblings founded Hexal AG, a generic drug maker which developed into the second-largest generic drug maker in the country. In 2005, the duo sold the company as well as their 68% stake in Eon Lab, which is currently based in the U.S., to Novartis for only $7.5 billion.

Eventually, they invested into several biotech firms in Germany through their Athos Service GmbH and Santo Holding. Thomas Strungmann is known to own an extensive collection of Swiss watches and modern art pieces.